TABLE I. Results of initial biochemistry investigations (reference ranges are given in brackets) TSH = Thyroid-stimulating hormone; T. = thyroxine; LH = luteinizing hormone; FSH = follicle-stimulating hormone; Hb = haemoglobin.
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The results of the biochemistry tests to assess liver and endocrine function are shown in Table  I . There was no evidence of glucose intolerance but hypopituitarism causing secondary hypothyroidism and hypogonadism was diagnosed and dynamic pituitary function tests were performed. The results are presented in Table 2 and show impaired thyroid-stimulating hormone (TSH), luteinizing hormone (LH) and follicle stimulating hormone (FSH) response. There were normal prolactin and cortisol responses. Hypogonadism and hypothyroidism due to hypopituitarism were confirmed. Plain X-ray of his ankles showed typical joint space narrowing with some subchondral cysts and osteophytes. Calcium deposits were seen in the cartilage. Computerized tomography scan of the pituitary showed no localized lesion.
He was treated with fortnightly venesection to reduce body iron stores and with replacement thyroxine and testosterone. He soon felt considerably better. After 12 months his liver enzymes had returned to normal and his serum ferritin was 1500 ngjL. Twenty-four months from diagnosis and after removal of 60 units of blood his serum ferritin was 230 ngjL and his haemoglobin had fallen to 130 gjL. His
Additional key phrases: hypothyroidism; impotence; iron studies; screening Hereditary haemochromatosis (HH) is characterized by excess stores of body iron which result in tissue damage. The classical presentation of unexplained cardiomegaly, hepatomegaly and cirrhosis, skin pigmentation and diabetes mellitus typically occurs in the advanced stages of the disease. Common features at diagnosis are now known to include weakness and lethargy, arthralgia and hypopituitary hypogonadism. A patient is presented here who also had secondary hypothyroidism, which has been reported much less frequently.
CASE HISTORY
A 53-year-old university professor, had pain, swelling and discoloration of both his ankles. This caused him considerable discomfort. After 2 years' hospital treatment and non-steroidal anti-inflammatory drugs there was no improvement and he referred himself to an acupuncturist. She examined him and recommended that he go to his general practitioner for iron studies. Serum iron was 33 J-lmoljL (12-30), total iron binding capacity 33 J-lmoljL (40-70), transferrin saturation 100% «33%) and serum ferritin 7429 ngjL (20-385). The patient was referred to a clinician to whom he gave the following history: he had been lethargic and lacked stamina for 3 years; had abdominal discomfort diagnosed as irritable bowel syndrome for 8 years; had headaches and light headedness for 18 months; and loss of libido and impotence for 5 years. He shaved every other day. He took 8-10 units of alcohol a week. His father had died of carcinoma of the liver. He had two brothers who were fit and well.
On examination he looked sallow and unwell. He had an enlarged liver and spleen. Both his ankles were swollen with purplish-blue discoloration of the skin and his testes were small and atrophied. Hereditary haemochromatosis was diagnosed. arthropathy showed no improvement. His liver and spleen were no longer palpable. His sense of well-being and libido had returned to normal.
DISCUSSION
This man presented with arthritis which occurs at presentation in nearly 50% of patients with HH.l,2 The arthritis is due to deposition of calcium pyrophosphate crystals in cartilage resulting in chondrocalcinosis. As in this patient there is joint space narrowing, subchondral cysts and bone sclerosis. The joints most commonly affected are the second and third metacarpophalangeal joints of the hands, ankles and knees. Arthritis is a sufficiently common presenting symptom to make the case for performing iron studies routinely in patients with sero-negative arthritis who present to the orthopaedic or rheumatology clinic.? Hypopituitary hypogonadism occurs in about 38% (15-75%) of patients with HH4,S and is due to deposition of iron in the gonadotrophs. Although affected women can undergo an early menopause, hypogonadism occurs much more frequently in men. In 64 people (male and female) who were homozygous for the allele" hypopituitary hypogonadism was found in five men. After treatment by venesection serum testosterone and secondary sexual characteristics returned to normal in two patients after 4 'I, and 6 years, respectively. This indicates that iron deposition is reversible. To find deposits of iron in thyrotrophs is much less commons? and where hypothyroidism does occur it is usually due to iron deposits in the thyroid gland itself. A 52-year-old man has recently been described in whom hypopituitarism due to haemochromatosis has reversed 10 years after diagnosis and Ann Clin Biochem 1996: 33 treatment of the condition," Similar reversal has been seen in three other cases.?
HH occurs with increased frequency in the population with Northern European ancestry, where the incidence of the homozygote is 3 per 1000 and the heterozygote is I in 100 (10) . It is 5-10 times more common in men than women and clinical expression is variable. Many patients with symptomatic HH consume alcohol to excess. There is a particular association with the A3 BI4 and A3 B7 markers."
HH occurs with such frequency that it is well worth screening other family members-particularly siblings." The father of this patient died of carcinoma of the liver which is interesting since this tumour occurs with an increased incidence ( x 200) in affected individuals.' One of his brothers has a serum iron of 15·6J.lmol/L, serum TIBC 46·8 J.lmol/L, 33% transferrin saturation and serum ferritin 462 J.lg/L. HLA type of the patient is Al All; B5 B7 B17; Bw4 and of his brother Al A2; B17 B62(l5); Bw4, 6. They are clearly not HLA identical. The second brother refuses to be tested. Our patient has no children.
The frequent incidence of the gene for HH and the marked improvement in well being once treatment is instituted in affected individuals, has led to a call for screening of patients presenting to diabetic and rheumatology clinicsI,10,1I or even in the general population.F Iron studies are cheap and may prove more beneficial to patients than some of the screening tests already regarded as routine and acceptable like cholesterol, thyroid or menopausal testing.
Diagnostic awareness of this condition should be increased amongst physicians and surgeons. This patient had complained of symptoms for more than 5 years but it was a practitioner in alternative medicine whose clinical acumen has helped him to recovery.
